Resistant form of helicobacter pylori in development of stomach MALT lymphoma

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter M. Mallaev
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors M. Mallaev1, A. Yusupbekov2
  • 1Tashkent Medical Academy, Tashkent, Uzbekistan, /
  • 2National Cancer Research Centre, Tashkent, Uzbekistan, /

Abstract

The discovery of H. Pylori and the proof of its leading role in the development of most of gastrointestinal diseases has radically changed the approach to their treatment. The main reason for the ineffectiveness of current treatment program is based on a point mutation of the genome HP and uncontrolled use of modern antimicrobial drugs.